These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30967527)

  • 41. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
    Zheng JF; Guo NH; Zi FM; Cheng J
    Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA MIAT/miR-148b/PAPPA axis modifies cell proliferation and migration in ox-LDL-induced human aorta vascular smooth muscle cells.
    Zhou Y; Ma W; Bian H; Chen Y; Li T; Shang D; Sun H
    Life Sci; 2020 Sep; 256():117852. PubMed ID: 32470448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis.
    Yao L; Zhou B; You L; Hu H; Xie R
    Mol Biol Rep; 2020 Apr; 47(4):2605-2617. PubMed ID: 32130618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.
    Vaiou M; Pangou E; Liakos P; Sakellaridis N; Vassilopoulos G; Dimas K; Papandreou C
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2141-58. PubMed ID: 27530445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The LncRNA MIAT is identified as a regulator of stemness-associated transcript in glioma.
    Amirmahani F; Vallian S; Asadi MH
    Mol Biol Rep; 2023 Jan; 50(1):517-530. PubMed ID: 36352177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
    Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
    Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homoharringtonine enhances bortezomib antimyeloma activity in myeloma cells adhesion to bone marrow stromal cells and in SCID mouse xenografts.
    Chen P; Yuan Q; Yang H; Wen X; You P; Hou D; Xie J; Cheng Y; Huang H
    Leuk Res; 2017 Jun; 57():119-126. PubMed ID: 28463768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing
    Zhang J; Chen M; Chen J; Lin S; Cai D; Chen C; Chen Z
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28246353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma.
    Lipchick BC; Utley A; Han Z; Moparthy S; Yun DH; Bianchi-Smiraglia A; Wolff DW; Fink E; Liu L; Furdui CM; Lee J; Lee KP; Nikiforov MA
    Blood Adv; 2021 Apr; 5(7):1933-1946. PubMed ID: 33821992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis.
    Li QY; Chen L; Hu N; Zhao H
    Biomed Pharmacother; 2018 Jul; 103():1727-1732. PubMed ID: 29864963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib.
    Łuczkowska K; Kulig P; Baumert B; Machaliński B
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.
    Salem K; McCormick ML; Wendlandt E; Zhan F; Goel A
    Redox Biol; 2015; 4():23-33. PubMed ID: 25485927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
    Xian D; Zhao Y
    J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.
    Jin S; Li B; Zhang B; Gao X; Jia X; Xu L; Chang S; Hu K; Wang G; Xu Z; Zhang T; Song D; Yang G; Wu X; Zhu H; Huang C; Lu Y; Shi J; Zhu W; Chen G
    Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):1884-1891. PubMed ID: 38009004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma.
    Lee SW; Yeon SK; Kim GW; Lee DH; Jeon YH; Yoo J; Kim SY; Kwon SH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms.
    Yang L; Zhang S; George SK; Teng R; You X; Xu M; Liu H; Sun X; Amin HM; Shi W
    Oncotarget; 2015 Jun; 6(17):14953-69. PubMed ID: 25879451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.
    Brünnert D; Kraus M; Stühmer T; Kirner S; Heiden R; Goyal P; Driessen C; Bargou RC; Chatterjee M
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1666-1676. PubMed ID: 30954557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis.
    Zhang C; Xie L; Liang H; Cui Y
    IUBMB Life; 2019 Jul; 71(7):845-853. PubMed ID: 30629798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.